pebble biotechnology laboratories ltd
pebble biotechnology laboratories ltd Company Information
Company Number
11278041
Next Accounts
97 days late
Shareholders
james fildes
trustech smart healthcare ventures ltd
View AllGroup Structure
View All
Industry
Research and experimental development on biotechnology
Registered Address
122, beech court hollin lane, styal, wilmslow, SK9 4LD
Website
perfusionbiotechnology.compebble biotechnology laboratories ltd Estimated Valuation
Pomanda estimates the enterprise value of PEBBLE BIOTECHNOLOGY LABORATORIES LTD at £742.1k based on a Turnover of £568.7k and 1.3x industry multiple (adjusted for size and gross margin).
pebble biotechnology laboratories ltd Estimated Valuation
Pomanda estimates the enterprise value of PEBBLE BIOTECHNOLOGY LABORATORIES LTD at £0 based on an EBITDA of £-37.8k and a 5.14x industry multiple (adjusted for size and gross margin).
pebble biotechnology laboratories ltd Estimated Valuation
Pomanda estimates the enterprise value of PEBBLE BIOTECHNOLOGY LABORATORIES LTD at £231.2k based on Net Assets of £129.1k and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pebble Biotechnology Laboratories Ltd Overview
Pebble Biotechnology Laboratories Ltd is a live company located in wilmslow, SK9 4LD with a Companies House number of 11278041. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in March 2018, it's largest shareholder is james fildes with a 56.7% stake. Pebble Biotechnology Laboratories Ltd is a young, small sized company, Pomanda has estimated its turnover at £568.7k with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Pebble Biotechnology Laboratories Ltd Health Check
Pomanda's financial health check has awarded Pebble Biotechnology Laboratories Ltd a 2 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
3 Strong
2 Regular
6 Weak
Size
annual sales of £568.7k, make it smaller than the average company (£2.9m)
- Pebble Biotechnology Laboratories Ltd
£2.9m - Industry AVG
Growth
3 year (CAGR) sales growth of 70%, show it is growing at a faster rate (13.1%)
- Pebble Biotechnology Laboratories Ltd
13.1% - Industry AVG
Production
with a gross margin of 53.8%, this company has a comparable cost of product (53.8%)
- Pebble Biotechnology Laboratories Ltd
53.8% - Industry AVG
Profitability
an operating margin of -7.1% make it less profitable than the average company (-0.2%)
- Pebble Biotechnology Laboratories Ltd
-0.2% - Industry AVG
Employees
with 8 employees, this is below the industry average (42)
8 - Pebble Biotechnology Laboratories Ltd
42 - Industry AVG
Pay Structure
on an average salary of £72.9k, the company has an equivalent pay structure (£72.9k)
- Pebble Biotechnology Laboratories Ltd
£72.9k - Industry AVG
Efficiency
resulting in sales per employee of £71.1k, this is less efficient (£129.4k)
- Pebble Biotechnology Laboratories Ltd
£129.4k - Industry AVG
Debtor Days
it gets paid by customers after 19 days, this is earlier than average (52 days)
- Pebble Biotechnology Laboratories Ltd
52 days - Industry AVG
Creditor Days
its suppliers are paid after 130 days, this is slower than average (62 days)
- Pebble Biotechnology Laboratories Ltd
62 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Pebble Biotechnology Laboratories Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 24 weeks, this is less cash available to meet short term requirements (32 weeks)
24 weeks - Pebble Biotechnology Laboratories Ltd
32 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 60.1%, this is a higher level of debt than the average (50.6%)
60.1% - Pebble Biotechnology Laboratories Ltd
50.6% - Industry AVG
PEBBLE BIOTECHNOLOGY LABORATORIES LTD financials
Pebble Biotechnology Laboratories Ltd's latest turnover from March 2023 is estimated at £568.7 thousand and the company has net assets of £129.1 thousand. According to their latest financial statements, Pebble Biotechnology Laboratories Ltd has 8 employees and maintains cash reserves of £91 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|---|---|
| Turnover | |||||
| Other Income Or Grants | |||||
| Cost Of Sales | |||||
| Gross Profit | |||||
| Admin Expenses | |||||
| Operating Profit | |||||
| Interest Payable | |||||
| Interest Receivable | |||||
| Pre-Tax Profit | |||||
| Tax | |||||
| Profit After Tax | |||||
| Dividends Paid | |||||
| Retained Profit | |||||
| Employee Costs | |||||
| Number Of Employees | 8 | 3 | 1 | 1 | |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|---|---|
| Tangible Assets | 14,269 | 1,628 | |||
| Intangible Assets | |||||
| Investments & Other | |||||
| Debtors (Due After 1 year) | |||||
| Total Fixed Assets | 14,269 | 1,628 | |||
| Stock & work in progress | |||||
| Trade Debtors | 30,002 | 29,745 | 13,047 | ||
| Group Debtors | |||||
| Misc Debtors | 188,423 | 23,735 | 12 | 12 | |
| Cash | 90,962 | 152,842 | 1,322 | 3,215 | |
| misc current assets | 4 | 268 | |||
| total current assets | 309,387 | 206,322 | 1,338 | 3,495 | 13,047 |
| total assets | 323,656 | 207,950 | 1,338 | 3,495 | 13,047 |
| Bank overdraft | |||||
| Bank loan | |||||
| Trade Creditors | 94,211 | 24,523 | |||
| Group/Directors Accounts | |||||
| other short term finances | |||||
| hp & lease commitments | |||||
| other current liabilities | 100,347 | 19,148 | 360 | ||
| total current liabilities | 194,558 | 43,671 | 360 | ||
| loans | |||||
| hp & lease commitments | |||||
| Accruals and Deferred Income | 1,080 | ||||
| other liabilities | |||||
| provisions | |||||
| total long term liabilities | 1,080 | ||||
| total liabilities | 194,558 | 43,671 | 360 | 1,080 | |
| net assets | 129,098 | 164,279 | 1,338 | 3,135 | 11,967 |
| total shareholders funds | 129,098 | 164,279 | 1,338 | 3,135 | 11,967 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Operating Profit | |||||
| Depreciation | 2,574 | 255 | |||
| Amortisation | |||||
| Tax | |||||
| Stock | |||||
| Debtors | 164,945 | 53,468 | -13,035 | 13,047 | |
| Creditors | 69,688 | 24,523 | |||
| Accruals and Deferred Income | 81,199 | 19,148 | -360 | -720 | 1,080 |
| Deferred Taxes & Provisions | |||||
| Cash flow from operations | |||||
| Investing Activities | |||||
| capital expenditure | |||||
| Change in Investments | |||||
| cash flow from investments | |||||
| Financing Activities | |||||
| Bank loans | |||||
| Group/Directors Accounts | |||||
| Other Short Term Loans | |||||
| Long term loans | |||||
| Hire Purchase and Lease Commitments | |||||
| other long term liabilities | |||||
| share issue | |||||
| interest | |||||
| cash flow from financing | |||||
| cash and cash equivalents | |||||
| cash | -61,880 | 151,520 | -1,893 | 3,215 | |
| overdraft | |||||
| change in cash | -61,880 | 151,520 | -1,893 | 3,215 |
pebble biotechnology laboratories ltd Credit Report and Business Information
Pebble Biotechnology Laboratories Ltd Competitor Analysis
Perform a competitor analysis for pebble biotechnology laboratories ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in SK9 area or any other competitors across 12 key performance metrics.
pebble biotechnology laboratories ltd Ownership
PEBBLE BIOTECHNOLOGY LABORATORIES LTD group structure
Pebble Biotechnology Laboratories Ltd has no subsidiary companies.
Ultimate parent company
PEBBLE BIOTECHNOLOGY LABORATORIES LTD
11278041
pebble biotechnology laboratories ltd directors
Pebble Biotechnology Laboratories Ltd currently has 8 directors. The longest serving directors include Dr James Fildes (Mar 2018) and Mr Mark Claydon (Jul 2021).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr James Fildes | England | 49 years | Mar 2018 | - | Director |
| Mr Mark Claydon | England | 51 years | Jul 2021 | - | Director |
| Mr Douglas Stellman | United Kingdom | 63 years | Jul 2021 | - | Director |
| Mr Richard Smith | England | 57 years | Mar 2024 | - | Director |
| Mr Michael Nation | England | 64 years | Dec 2024 | - | Director |
| Mr Thierry Jean | England | 68 years | Dec 2024 | - | Director |
| Dr Leslie Russell | United Kingdom | 72 years | Dec 2024 | - | Director |
| Prof Marc Clancy | England | 56 years | Dec 2024 | - | Director |
P&L
March 2023turnover
568.7k
+117%
operating profit
-40.4k
0%
gross margin
53.9%
+10.55%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
129.1k
-0.21%
total assets
323.7k
+0.56%
cash
91k
-0.4%
net assets
Total assets minus all liabilities
pebble biotechnology laboratories ltd company details
company number
11278041
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
March 2018
age
7
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2023
previous names
perfusion biotechnology ltd (November 2022)
perfusion research ltd (June 2021)
accountant
AZETS
auditor
-
address
122, beech court hollin lane, styal, wilmslow, SK9 4LD
Bank
-
Legal Advisor
-
pebble biotechnology laboratories ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to pebble biotechnology laboratories ltd.
pebble biotechnology laboratories ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PEBBLE BIOTECHNOLOGY LABORATORIES LTD. This can take several minutes, an email will notify you when this has completed.
pebble biotechnology laboratories ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
